Page last updated: 2024-12-08

gant 61

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

GANT 61: a sonic hedgehog pathway inhibitor and Gli inhibitor; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

GANT61 : An aminal that is hexahydropyrimidine which is substituted on each nitrogen by a 2-(dimethylamino)benzyl group, and at the aminal carbon by a pyridin-4-yl group. A Hedgehog signaling pathway and Gli protein inhibitor. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID421610
CHEMBL ID471728
CHEBI ID140908
CHEBI ID94276
SCHEMBL ID12831665
MeSH IDM0548592

Synonyms (54)

Synonym
2,2'-(2-(pyridin-4-yl)-dihydropyrimidine-1,3(2h,4h)-diyl)bis(methylene)bis(n,n-dimethylbenzenamine)
NSC136476 ,
2-((3-(2-(dimethylamino)benzyl)-2-(4-pyridinyl)tetrahydro-1(2h)-pyrimidinyl)methyl)-n,n-dimethylaniline
NCGC00014352
nsc-136476
NCI136476
NCISTRUC1_001747
NCISTRUC2_001814
NCGC00097461-01
bdbm50249557
2-((3-(2-(dimethylamino)benzyl)-2-(pyridin-4-yl)-tetrahydropyrimidin-1(2h)-yl)methyl)-n,n-dimethylbenzenamine
2,2''-(2-(pyridin-4-yl)dihydropyrimidine-1,3(2h,4h)-diyl)bis(methylene)bis(n,n-dimethylaniline)
2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-n,n-dimethylaniline
CHEMBL471728 ,
gant61
2-({3-[2-(dimethylamino)benzyl]-2-(pyridin-4-yl)tetrahydropyrimidin-1(2h)-yl}methyl)-n,n-dimethylaniline
gant-61
nsc 136476
CHEBI:140908
gant 61
CCG-37862
NCGC00014352-02
2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-(4-pyridyl)hexahydropyrimidin-1-yl]methyl]-n,n-dimethyl-aniline
NCGC00014352-03
gant 61(nsc 136476)
500579-04-4
BRD-K09485525-001-02-1
SCHEMBL12831665
HY-13901
CS-1528
c27h35n5
2,2'-[[dihydro-2-(4-pyridinyl)-1,3(2h,4h)-pyrimidinediyl]bis(methylene)]bis[n,n-dimethylbenzenamine
2,2'-((dihydro-2-(4-pyridinyl)-1,3(2h,4h)-pyrimidinediyl)bis(methylene))bis(n,n-dimethyl)-benzenamine
HB3394
2,2'-((2-(pyridin-4-yl)dihydropyrimidine-1,3(2h,4h)-diyl)bis(methylene))bis(n,n-dimethylaniline)
AC-32720
AKOS024457467
DTXSID50329591
EX-A339
2,2'-(2-(pyridin-4-yl)dihydropyrimidine-1,3(2h,4h)-diyl)bis(methylene)bis(n,n-dimethylaniline)
CHEBI:94276
(2,2'-[[dihydro-2-(4-pyridinyl)-1,3(2h,4h)-pyrimidinediyl]bis(methylene)]bis(n,n-dimethylbenzenamine))
gnt61
gant61(nsc 136476)
FT-0715623
BCP08050
Q27166081
S8075
A13252
SB19316
NCGC00014352-14
AMY39942
2-[(3-{[2-(dimethylamino)phenyl]methyl}-2-(pyridin-4-yl)-1,3-diazinan-1-yl)methyl]-n,n-dimethylaniline
AS-57126

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" GANT61 inhibited the growth and metastasis of HeLa cervical cancer cells upon their transplantation into nude mice, and we preliminarily propose that GANT61 is safe for nude mice."( The inhibitory effect and safety of GANT61 on HeLa cells in nude mice.
Chang, Y; Chen, H; Duan, J; Le, F; Mou, F; Wu, W, 2020
)
0.56

Compound-Compound Interactions

ExcerptReferenceRelevance
" The treatment using GANT61 in combination with the inhibition of mTOR, which is another key molecule in pancreatic CSCs, resulted in the efficient reduction of cell viability and sphere formation of an inhibitor-resistant cell line, showing the strong efficacy and wide range applicability to pancreatic CSC-like cells."( Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
Ding, Q; Kosai, K; Matsubara, S; Miyazaki, Y; Takao, S; Tsukasa, K; Yoshimitsu, M, 2016
)
0.43
" Hence, there is an increasing interest in targeting the Hh pathway in combination with radiotherapy."( Targeting the Hedgehog pathway in combination with X‑ray or carbon ion radiation decreases migration of MCF‑7 breast cancer cells.
Baatout, S; Baselet, B; Belmans, N; Haustermans, K; Isebaert, S; Janssen, A; Konings, K; Lamers, G; Moreels, M; Vermeesen, R, 2019
)
0.51

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" The NPs induced cytotoxic effects in breast cancer cells at a mid-minimal dosage followed by cell death via autophagy and apoptosis, reduction in their target protein expression along with compromising the self-renewal property of CSCs as revealed by their in vitro cell studies."( GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma.
Borah, A; Kumar, DS; Maekawa, T; Nakajima, Y; Palaninathan, V; Pillai, SC; Rochani, AK, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
Hedgehog signaling pathway inhibitorAny pathway inhibitor that inhibits the Hedgehog signalling pathway.
glioma-associated oncogene inhibitorAn inhibitor of any of the glioma-associated oncogene (GLI) proteins.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
dialkylarylamine
tertiary amino compoundA compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups.
tertiary amino compoundA compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups.
pyridinesAny organonitrogen heterocyclic compound based on a pyridine skeleton and its substituted derivatives.
substituted aniline
aminalCompounds having two amino groups bonded to the same carbon, R2C(NR2)2.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (30)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Fumarate hydrataseHomo sapiens (human)Potency11.77040.00308.794948.0869AID1347053
PPM1D proteinHomo sapiens (human)Potency26.21230.00529.466132.9993AID1347411
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency3.54810.011212.4002100.0000AID1030
EWS/FLI fusion proteinHomo sapiens (human)Potency20.43140.001310.157742.8575AID1259252; AID1259253; AID1259255; AID1259256
polyproteinZika virusPotency11.77040.00308.794948.0869AID1347053
cytochrome P450 2D6 isoform 1Homo sapiens (human)Potency1.25890.00207.533739.8107AID891
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency3.16230.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency3.16230.316212.765731.6228AID881
Interferon betaHomo sapiens (human)Potency26.21230.00339.158239.8107AID1347411
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency3.16230.00638.235039.8107AID881
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Zinc finger protein GLI1Homo sapiens (human)IC50 (µMol)40.00000.62002.54507.1000AID491229
Zinc finger protein GLI1Mus musculus (house mouse)IC50 (µMol)5.00005.00005.00005.0000AID1525383
Zinc finger protein GLI2Mus musculus (house mouse)IC50 (µMol)5.00005.00005.00005.0000AID1525383
Sonic hedgehog proteinMus musculus (house mouse)IC50 (µMol)5.00000.00301.19115.0000AID351760
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (77)

Processvia Protein(s)Taxonomy
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIZinc finger protein GLI1Homo sapiens (human)
osteoblast differentiationZinc finger protein GLI1Homo sapiens (human)
regulation of DNA-templated transcriptionZinc finger protein GLI1Homo sapiens (human)
smoothened signaling pathwayZinc finger protein GLI1Homo sapiens (human)
spermatid developmentZinc finger protein GLI1Homo sapiens (human)
ventral midline developmentZinc finger protein GLI1Homo sapiens (human)
positive regulation of cell population proliferationZinc finger protein GLI1Homo sapiens (human)
regulation of smoothened signaling pathwayZinc finger protein GLI1Homo sapiens (human)
response to woundingZinc finger protein GLI1Homo sapiens (human)
epidermal cell differentiationZinc finger protein GLI1Homo sapiens (human)
dorsal/ventral pattern formationZinc finger protein GLI1Homo sapiens (human)
proximal/distal pattern formationZinc finger protein GLI1Homo sapiens (human)
cerebellar cortex morphogenesisZinc finger protein GLI1Homo sapiens (human)
pituitary gland developmentZinc finger protein GLI1Homo sapiens (human)
lung developmentZinc finger protein GLI1Homo sapiens (human)
prostate gland developmentZinc finger protein GLI1Homo sapiens (human)
regulation of osteoblast differentiationZinc finger protein GLI1Homo sapiens (human)
positive regulation of DNA replicationZinc finger protein GLI1Homo sapiens (human)
positive regulation of smoothened signaling pathwayZinc finger protein GLI1Homo sapiens (human)
positive regulation of DNA-templated transcriptionZinc finger protein GLI1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIZinc finger protein GLI1Homo sapiens (human)
digestive tract morphogenesisZinc finger protein GLI1Homo sapiens (human)
notochord regressionZinc finger protein GLI1Homo sapiens (human)
positive regulation of cardiac muscle cell proliferationZinc finger protein GLI1Homo sapiens (human)
negative regulation of canonical Wnt signaling pathwayZinc finger protein GLI1Homo sapiens (human)
liver regenerationZinc finger protein GLI1Homo sapiens (human)
positive regulation of cell cycle G1/S phase transitionZinc finger protein GLI1Homo sapiens (human)
regulation of hepatocyte proliferationZinc finger protein GLI1Homo sapiens (human)
regulation of transcription by RNA polymerase IIZinc finger protein GLI1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIZinc finger protein GLI2Mus musculus (house mouse)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (21)

Processvia Protein(s)Taxonomy
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
transcription cis-regulatory region bindingZinc finger protein GLI1Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingZinc finger protein GLI1Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificZinc finger protein GLI1Homo sapiens (human)
DNA bindingZinc finger protein GLI1Homo sapiens (human)
chromatin bindingZinc finger protein GLI1Homo sapiens (human)
protein bindingZinc finger protein GLI1Homo sapiens (human)
microtubule bindingZinc finger protein GLI1Homo sapiens (human)
metal ion bindingZinc finger protein GLI1Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificZinc finger protein GLI1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingZinc finger protein GLI1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (17)

Processvia Protein(s)Taxonomy
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
cytoplasmZinc finger protein GLI1Homo sapiens (human)
nucleusZinc finger protein GLI1Homo sapiens (human)
nucleoplasmZinc finger protein GLI1Homo sapiens (human)
cytoplasmZinc finger protein GLI1Homo sapiens (human)
cytosolZinc finger protein GLI1Homo sapiens (human)
axonemeZinc finger protein GLI1Homo sapiens (human)
ciliary tipZinc finger protein GLI1Homo sapiens (human)
ciliary baseZinc finger protein GLI1Homo sapiens (human)
GLI-SUFU complexZinc finger protein GLI1Homo sapiens (human)
nucleusZinc finger protein GLI1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
nucleoplasmZinc finger protein GLI2Mus musculus (house mouse)
cytosolZinc finger protein GLI2Mus musculus (house mouse)
extracellular regionSonic hedgehog proteinMus musculus (house mouse)
nucleoplasmSonic hedgehog proteinMus musculus (house mouse)
endoplasmic reticulum lumenSonic hedgehog proteinMus musculus (house mouse)
plasma membraneSonic hedgehog proteinMus musculus (house mouse)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (91)

Assay IDTitleYearJournalArticle
AID1291445Inhibition of Hh signaling pathway in Sufu deficient MEF cells assessed as downregulation of Ptch1 mRNA expression at 10 uM after 24 hrs by qRT-PCR analysis2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Development of thieno- and benzopyrimidinone inhibitors of the Hedgehog signaling pathway reveals PDE4-dependent and PDE4-independent mechanisms of action.
AID358328Reduction in GLI1 expression in human PANC1 cells at 5 uM2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID1480306Increase in lysosome size in human fibroblasts after 24 hrs by LysoTracker Red DND-99-based assay2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID509548Antagonist activity at hedgehog receptor2010Bioorganic & medicinal chemistry, Sep-15, Volume: 18, Issue:18
Modulators of the hedgehog signaling pathway.
AID1480303Inhibition of recombinant cathepsin L (unknown origin) at 10 uM using Ac-FR-AFC as substrate preincubated for 29 mins followed by substrate addition by fluorescence-based assay2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID358344Antiproliferative activity against mouse embryonic fibroblast at 10 uM assessed as microarray method2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358318Cytotoxicity against mouse NIH3T3 cells at 10 uM after 48 hrs assessed as reduction in cell viability by MTS assay2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID1480304Inhibition of recombinant cathepsin B (unknown origin) at 10 uM using Ac-RR-AFC as substrate preincubated for 29 mins followed by substrate addition by fluorescence-based assay2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID358345Inhibition of GLI via PKA activation in HEK293 cells2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID1480298Inhibition of Ebolavirus glycoprotein/matrix protein VP40 entry in human HeLa cells after 4.5 hrs beta-lactamase reporter assay2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID491229Inhibition of human Gli1-mediated transcriptional activity in human Rh30 cells after 24 hrs by luciferase reporter gene assay2010Bioorganic & medicinal chemistry, Jul-01, Volume: 18, Issue:13
Amide conjugates of ketoprofen and indole as inhibitors of Gli1-mediated transcription in the Hedgehog pathway.
AID358334Inhibition of Gli1 dependent growth of human PANC1 cells at 5 uM2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358329Reduction in PTCH expression in human PANC1 cells at 5 uM2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358353Antiproliferative activity against Ptch deficient mouse embryonic fibroblast at 10 uM by BrdU incorporation2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358325Reduction in expression of Hedgehog target gene Gli1 in Sufu deficient mouse embryonic fibroblast2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358340Induction of apoptosis in HEK293 cells assessed as caspase3/7 cleavage by luminometric assay2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358320Cytotoxicity against human HepG2 cells at 10 uM after 48 hrs assessed as reduction in cell viability by MTS assay2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358347Inhibition of nuclear accumulation of GLI mutant in HEK293 cells2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358352Effect on Hedgehog signaling in mouse NIH3T3 cells assessed as transactivation of Ras-Raf-Mek-Mapk cascade2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID1291444Cytotoxicity against mouse TM3 cells assessed as cell viability after 48 hrs by Cell Titer Glo assay2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Development of thieno- and benzopyrimidinone inhibitors of the Hedgehog signaling pathway reveals PDE4-dependent and PDE4-independent mechanisms of action.
AID358322Reduction of Gil1 mRNA levels at 10 uM in Ptch deficient mouse embryonic fibroblast2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID1291442Inhibition of Hh signaling pathway in Shh-LIGHT2 incorporated mouse NIH 3T3 cells assessed as downregulation of Gli1 gene expression by luciferase reporter gene assay2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Development of thieno- and benzopyrimidinone inhibitors of the Hedgehog signaling pathway reveals PDE4-dependent and PDE4-independent mechanisms of action.
AID358336Antitumor activity in GLI1 positive human 22Rv cells xenografted mouse model at 50 mg/kg, sc after 18 days2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358330Reduction in GlI1 expression in human 22Rv cells at 5 uM2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID1480300Selectivity index, ratio of cytotoxic activity for human HeLa cells to IC50 for Ebolavirus glycoprotein/matrix protein VP40 entry in human HeLa cells2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID358349Effect on Hedgehog signaling in mouse NIH3T3 cells assessed as activation of TNF signaling2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358332Inhibition of Gli1 dependent growth of human HepG2 cells at 5 uM2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358339Induction of apoptosis in human Jurkat cells assessed as caspase3/7 cleavage by luminometric assay2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358342Induction of apoptosis in mouse NIH3T3 cells assessed as caspase3/7 cleavage by luminometric assay2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358319Cytotoxicity against wild type mouse embryonic fibroblast at 10 uM after 48 hrs assessed as reduction in cell viability by MTS assay2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID1480299Selectivity index, ratio of cytotoxic activity for HEK293 cells to IC50 for Ebolavirus glycoprotein/matrix protein VP40 entry in human HeLa cells2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID358323Reduction of Ptch1-lacZ level in mouse embryonic fibroblast by luminometric assay2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358333Inhibition of Gli1 dependent growth of human Jurkat cells at 5 uM2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358335Inhibition of Gli1 dependent growth of human 22Rv cells at 5 uM2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358315Reduction of GLI1 mediated transcription in HEK293 cells by luciferase reporter assay2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID351760Inhibition of SHH in mouse Shh Light2 cells by GLI-responsive firefly luciferase reporter gene assay2009Journal of medicinal chemistry, Jul-09, Volume: 52, Issue:13
Hedgehog-Gli signaling pathway inhibitors as anticancer agents.
AID1525383Inhibition of GLI1/GLI2 in mouse Shh Light2 cells assessed as reduction in endogenous hedgehog signalling in presence of Smo agonist SAG by luciferase reporter gene assay2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies.
AID358341Induction of apoptosis in human DU146 cells assessed as caspase3/7 cleavage by luminometric assay2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID1882264Induction of mitotic arrest in human multiple myeloma cells2022European journal of medicinal chemistry, Feb-05, Volume: 229A review on the treatment of multiple myeloma with small molecular agents in the past five years.
AID358348Inhibition of nuclear accumulation of wild type GLI in HEK293 cells2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358331Reduction in PTCH expression in human 22Rv cells at 5 uM2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358317Inhibition of GLI1 induced hedgehog signaling in mouse NIH3T3 cells2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID1480302Binding affinity to Ebolavirus glycoprotein/matrix protein VP40 at 50 uM incubated for 10 mins by thermal shift assay2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID358350Effect on Hedgehog signaling in mouse NIH3T3 cells assessed as activation of NF kappaB2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358351Effect on Hedgehog signaling in mouse NIH3T3 cells assessed as transactivation of glucocorticoid receptor2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358324Inhibition of beta galactosidase in HEK293 cells2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID1291443Inhibition of Hh signaling pathway in mouse TM3 cells assessed as downregulation of Gli1 gene expression after 48 hrs by luciferase reporter gene assay2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Development of thieno- and benzopyrimidinone inhibitors of the Hedgehog signaling pathway reveals PDE4-dependent and PDE4-independent mechanisms of action.
AID358321Inhibition of Hedgehog signaling in human Shh-L2 cells2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID1196822Inhibition of GLI (unknown origin) expressed in HEK293 cells assessed as reduction in GLI-mediated transcription at 30 uM2015Journal of medicinal chemistry, Feb-12, Volume: 58, Issue:3
Discovery of small molecule inhibitors to Krüppel-like factor 10 (KLF10): implications for modulation of T regulatory cell differentiation.
AID1291441Inhibition of Hh signaling pathway in Sufu deficient MEF cells assessed as downregulation of Gli1 mRNA expression at 10 uM after 24 hrs by qRT-PCR analysis2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Development of thieno- and benzopyrimidinone inhibitors of the Hedgehog signaling pathway reveals PDE4-dependent and PDE4-independent mechanisms of action.
AID358338Induction of apoptosis in human 22Rv1 cells assessed as caspase3/7 cleavage by luminometric assay2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358337Induction of apoptosis in human HepG2 cells assessed as caspase3/7 cleavage by luminometric assay2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358316Reduction of GLI2 mediated transcription in HEK293 cells by luciferase reporter assay2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358346Alteration in DNA binding to GLI1 in HEK293 cells2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358327Inhibition of Hedgehog/Gli1 mediated transformation in mouse NIH3T3 cells at 10 uM2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID358326Reduction in expression of Hedgehog target gene Hip1 in Sufu deficient mouse MEF cells2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID1480305Inhibition of NPC1 in human fibroblasts assessed as increase in cholesterol accumulation after 24 hrs by filipin staining-based assay2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID358343Reduction of expression of PTCH mRNA in human 22Rv cells2007Proceedings of the National Academy of Sciences of the United States of America, May-15, Volume: 104, Issue:20
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists.
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (159)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (1.26)29.6817
2010's115 (72.33)24.3611
2020's42 (26.42)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.29 (24.57)
Research Supply Index5.08 (2.92)
Research Growth Index6.22 (4.65)
Search Engine Demand Index33.89 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (3.75%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other154 (96.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]